Life Sciences Insights from Industry

RSS
"Insights from Industry" is a dynamic series of interviews at the cutting edge of the life sciences industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
CRISPR/Cas9 genome editing: an interview with Maja Petkovic

CRISPR/Cas9 genome editing: an interview with Maja Petkovic

Life science investment in Northern England: an interview with Dr Geoff Davison, CEO, Bionow

Life science investment in Northern England: an interview with Dr Geoff Davison, CEO, Bionow

Botanical dietary supplement screening with NMR and MS – an interview with Kim Colson

Botanical dietary supplement screening with NMR and MS – an interview with Kim Colson

NMR spectroscopy for in-vitro diagnostic research: an interview with Dr. Manfred Spraul, Director of NMR Applications, Bruker BioSpin

NMR spectroscopy for in-vitro diagnostic research: an interview with Dr. Manfred Spraul, Director of NMR Applications, Bruker BioSpin

miRNA expression and inhibition: an interview with Maja Petkovic, AMSBIO

miRNA expression and inhibition: an interview with Maja Petkovic, AMSBIO

3D cell culture: an interview with Dr. Elad Katz, Senior Scientist, AMSBIO

3D cell culture: an interview with Dr. Elad Katz, Senior Scientist, AMSBIO

Nanomedicine – past, present and future: an interview with Frank Boehm, CEO NanoApps Medical Inc.

Nanomedicine – past, present and future: an interview with Frank Boehm, CEO NanoApps Medical Inc.

Nanoparticle analysis: an interview with Bernardo Cordovez, CEO of Optofluidics

Nanoparticle analysis: an interview with Bernardo Cordovez, CEO of Optofluidics

The future of DNA sequencing: an interview with Barrett Bready, CEO of Nabsys

The future of DNA sequencing: an interview with Barrett Bready, CEO of Nabsys

Microplate readers: an interview with Ville Haaslahti, Managing Director, Hidex

Microplate readers: an interview with Ville Haaslahti, Managing Director, Hidex

Biomedical testing: an interview with Ed Moriarty, General Manager of the ElectroForce Systems Group of Bose Corporation

Biomedical testing: an interview with Ed Moriarty, General Manager of the ElectroForce Systems Group of Bose Corporation

Serialization: an interview with Dr. Sue Miles, UK Site Director at PCI - Packaging Coordinators Inc.

Serialization: an interview with Dr. Sue Miles, UK Site Director at PCI - Packaging Coordinators Inc.

Secure sample storage in Biobanking: an interview with Mr Jacko Duker, Procesmanager at the LifeLines Project

Secure sample storage in Biobanking: an interview with Mr Jacko Duker, Procesmanager at the LifeLines Project

Bioscience development: an interview with Dr E. Neil Lewis, Chief Technology Officer, Malvern Instruments

Bioscience development: an interview with Dr E. Neil Lewis, Chief Technology Officer, Malvern Instruments

New uses for old drugs: an interview with Kate Hudson-Farmer, PhD MBA, Senior Consultant, Cambridge Consultants

New uses for old drugs: an interview with Kate Hudson-Farmer, PhD MBA, Senior Consultant, Cambridge Consultants

Consumable selection: an interview with Rob Bunn, Marketing Program Manager EMEA at Agilent Technologies

Consumable selection: an interview with Rob Bunn, Marketing Program Manager EMEA at Agilent Technologies

Microcystins in drinking water: an interview with Rohan Thakur, VP of Bruker CAM

Microcystins in drinking water: an interview with Rohan Thakur, VP of Bruker CAM

Medical adhesives for reusable or disposable medical devices: an interview with Robert Michaels, VP of Technical Sales, Master Bond

Medical adhesives for reusable or disposable medical devices: an interview with Robert Michaels, VP of Technical Sales, Master Bond

Bioluminescence microscopy: an interview with Robert Schmalzigaug, Olympus America

Bioluminescence microscopy: an interview with Robert Schmalzigaug, Olympus America

Nanoparticles and cancer treatment: an interview with John Stroh, CEO of Nanospectra Biosciences

Nanoparticles and cancer treatment: an interview with John Stroh, CEO of Nanospectra Biosciences